Pharmaceutical businesses are increasingly focusing on undertaking a variety of R&D activities as well as outsourcing such activities to universities and private research organisations, which is increasing the number of new laboratory setups. As a result, demand for liquid handling systems rises, boosting market growth. Furthermore, in order to remain competitive in the rapidly expanding pharmaceutical and biotechnology medicines market, pharmaceutical corporations are increasingly outsourcing their research to privately-based contract research organisations (CRO).
The global Automated Liquid Handling Systems Market was worth USD 1,898.6 million in 2022 and is predicted to increase at a CAGR of 10.5% between 2023 and 2030.
Key Companies in the Automated Liquid Handling Systems Industry:
1. Qiagen N.V.: Established in 1984. Headquarters are located in Hilden, Germany. Qiagen provides proprietary sample and assay technologies for the extraction, purification, amplification, and interpretation of DNA, RNA, and proteins. The sales of the company are roughly evenly split between applications in life sciences and molecular diagnostics. Qiagen's revenue is almost entirely comprised of consumables, with the remainder coming from instruments and related services. The Americas generate the most revenue for the company (45% of 2021 sales), followed by EMEA (36%), and Asia-Pacific (19%).
2. Corning, Inc.: Corning Incorporated (NYSE: GLW), headquartered in Corning, New York, USA, was founded in 1851 and is one of the world's leading inventors in materials science. Ophthalmic lens manufacturer. The company designs and manufactures ophthalmic and photochromic lenses for use in medical devices and industrial applications. SpiderCloud (July 2017), STRAN Technologies (Dec 2016), and Alliance Fibre Optic Products (Apr 2016) are the most recent acquisitions.
3. Bio-Rad Laboratories Inc.: Built in 1952. With its headquarters in Hercules, California, Bio-Rad Laboratories creates, produces, and sells goods and services for the clinical diagnostics and life sciences industries. Bio-Rad produces, markets, and maintains test systems and specialised quality controls for clinical laboratories in the diagnostics sector (53% of revenue). The company creates and produces a variety of tools and reagents for use in research, the production of biopharmaceuticals, and food testing in the life sciences sector (47% of revenue). Major markets for the corporation are found in the Americas, Europe, Africa, and Asia-Pacific. Sartorius AG, a supplier of lab supplies and biopharmaceuticals, is 37% owned by Bio-Rad. Acquisition of Curiosity Diagnostics by Bio-Rad
4. PerkinElmer, Inc.: It was founded in 1931. Headquarters are in the United States. Revvity supplies pharmaceutical, biomedical, chemical, environmental, and general industrial markets with instruments, tests, services, and software solutions. The company is divided into two segments. The first segment is diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions include applications in life science, industrial, environmental, and food science. Revvity provides a wide range of goods and services, including genetic screening and environmental analytical tools, as well as informatics and enterprise software. SonoVol (Feb 2022), BioLegend (Jul 2021), and Sirion Biotech (Jun 2021) are the most recent acquisitions.
5. Agilent Technologies, Inc: Agilent, which was split off from Hewlett-Packard in 1999, has grown into a premier life sciences and diagnostics company. Agilent's measuring technologies now serve a diverse range of clients through its three operating segments: life science and applied tools, cross lab (consisting of life science and applied tools consumables and services), and diagnostics and genomics. More than half of its revenue comes from the biopharmaceutical, chemical, and advanced materials end sectors, but it also works with clinical labs, environmental, forensics, food, academic, and government-related organisations. In 2021, Agilent Technologies Inc. (NYSE: A) announced a definitive agreement to acquire Resolution Bioscience Inc., a pioneer in the development and marketing of next-generation sequencing (NGS)-based precision oncology products.
6. Danaher Corporation: Danaher's founders changed a real estate firm into an industrial-focused manufacturing firm in 1984. Danaher today primarily manufactures scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions, as a result of a sequence of mergers, acquisitions, and divestitures. The company announced plans to exit its environmental and applied solutions groups in 2023, leaving it only focused on life sciences and diagnostics in late 2022.
7. Thermo Fisher Scientific Inc: Established in 1956. Thermo Fisher Scientific is an American company that sells laboratory supplies, life science reagents, diagnostics equipment, and tools for use in science. As of mid-2022, the company operates through four segments: analytical technologies (15% of sales); speciality diagnostic products (10% of revenues); life science solutions (30% of revenues); and lab goods and services, which includes CRO services (51% of revenues).
*Definition: Automatic liquid handling systems are designed to speed up the pipetting and dispensing process while at the same time increasing the accuracy of workflows for different liquid types and volumes.
